Description
For the first time in Nigeria, the BARRIER study, a randomized controlled clinical trial evaluated and compared multiple liquid antacid brands in 220 patients.
Of the four brands assessed, one demonstrated consistent and statistically significant symptom improvement, with marked reductions in the severity and frequency of heartburn, regurgitation, and dyspepsia as early as Day 2. This brand also provided rapid onset of relief in under five minutes, with sustained comfort reported by 96% of patients and high overall satisfaction scores.
Click to learn more and discover which brand emerged as the most effective in antacid performance.